搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Clostridium difficile tRNA (guanine-N (7)-)-methyltransferase (trmB) CSB-YP623231CAAQ
CSB-EP623231CAAQ
CSB-BP623231CAAQ
CSB-MP623231CAAQ
CSB-EP623231CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Beta-catenin/armadillo-related protein 1 (bar-1), partial CSB-YP623232CXY
CSB-EP623232CXY
CSB-BP623232CXY
CSB-MP623232CXY
CSB-EP623232CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ectopic P granules protein 5 (epg-5), partial CSB-YP623233CXY
CSB-EP623233CXY
CSB-BP623233CXY
CSB-MP623233CXY
CSB-EP623233CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant GTP-binding protein cgp-1 (cgp-1), partial CSB-YP623234CXY
CSB-EP623234CXY
CSB-BP623234CXY
CSB-MP623234CXY
CSB-EP623234CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant WD repeat and FYVE domain-containing protein 2 (wdfy-2) CSB-YP623235CXY
CSB-EP623235CXY
CSB-BP623235CXY
CSB-MP623235CXY
CSB-EP623235CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Probable transcriptional regulatory protein CD630_07950 (CD630_07950) CSB-YP623236CAAQ
CSB-EP623236CAAQ
CSB-BP623236CAAQ
CSB-MP623236CAAQ
CSB-EP623236CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 3-isopropylmalate dehydratase large subunit (leuC) CSB-YP623237CAAQ
CSB-EP623237CAAQ
CSB-BP623237CAAQ
CSB-MP623237CAAQ
CSB-EP623237CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Probable septum site-determining protein MinC (minC) CSB-YP623238CAAQ
CSB-EP623238CAAQ
CSB-BP623238CAAQ
CSB-MP623238CAAQ
CSB-EP623238CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Phosphate acyltransferase (plsX) CSB-YP623239CAAQ
CSB-EP623239CAAQ
CSB-BP623239CAAQ
CSB-MP623239CAAQ
CSB-EP623239CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 50S ribosomal protein L19 (rplS) CSB-YP623240CAAQ
CSB-EP623240CAAQ
CSB-BP623240CAAQ
CSB-MP623240CAAQ
CSB-EP623240CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Putative Holliday junction resolvase (CD630_12850) CSB-YP623241CAAQ
CSB-EP623241CAAQ
CSB-BP623241CAAQ
CSB-MP623241CAAQ
CSB-EP623241CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Putative competence-damage inducible protein (cinA) CSB-YP623242CAAQ
CSB-EP623242CAAQ
CSB-BP623242CAAQ
CSB-MP623242CAAQ
CSB-EP623242CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Methionine import ATP-binding protein MetN (metN) CSB-YP623243CAAQ
CSB-EP623243CAAQ
CSB-BP623243CAAQ
CSB-MP623243CAAQ
CSB-EP623243CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Ketol-acid reductoisomerase (ilvC) CSB-YP623244CAAQ
CSB-EP623244CAAQ
CSB-BP623244CAAQ
CSB-MP623244CAAQ
CSB-EP623244CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Recombination protein RecR (recR) CSB-YP623245CAAQ
CSB-EP623245CAAQ
CSB-BP623245CAAQ
CSB-MP623245CAAQ
CSB-EP623245CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 50S ribosomal protein L7/L12 (rplL) CSB-YP623246CAAQ
CSB-EP623246CAAQ
CSB-BP623246CAAQ
CSB-MP623246CAAQ
CSB-EP623246CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Elongation factor G (fusA), partial CSB-YP623247CAAQ
CSB-EP623247CAAQ
CSB-BP623247CAAQ
CSB-MP623247CAAQ
CSB-EP623247CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 50S ribosomal protein L24 (rplX) CSB-YP623248CAAQ
CSB-EP623248CAAQ
CSB-BP623248CAAQ
CSB-MP623248CAAQ
CSB-EP623248CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 50S ribosomal protein L18 (rplR) CSB-YP623249CAAQ
CSB-EP623249CAAQ
CSB-BP623249CAAQ
CSB-MP623249CAAQ
CSB-EP623249CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Translation initiation factor IF-1 (infA) CSB-YP623250CAAQ
CSB-EP623250CAAQ
CSB-BP623250CAAQ
CSB-MP623250CAAQ
CSB-EP623250CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>